Tag: CanPath

CanPath Scientific Director presents at AGBT Meeting

Posted on by pathwp

Advances in Genome Biology and Technology (AGBT) is “considered the preeminent genome science and technology conference where top global researchers, leaders and innovators meet to announce new discoveries, cutting edge breakthroughs and to collaborate.” CanPath Scientific Director, Dr. Philip Awadalla attended the AGBT Precision Health meeting in San Diego, California from September 7-9, 2023. Dr. Read more about CanPath Scientific Director presents at AGBT Meeting[…]

New Publication – Depression, Anxiety and Risk of Cancer

Posted on by pathwp

We are pleased to share that the first results from the Psychosocial Factors and Cancer Incidence (PSY-CA) consortium have been published in Cancer. Led from the Netherlands by Dr. Lonneke van Tuijl and Dr. Joost Dekker, this study includes 18 cohorts with more than 300,000 participants including Atlantic PATH, the Ontario Health Study and CARTaGENE Read more about New Publication – Depression, Anxiety and Risk of Cancer[…]

COVID Global Mental Health Consortium Funded – 23 cohorts with 2.8 million participants

Posted on by pathwp

We’re excited to share that the collaborative project, “International Evaluation of Modifiable Social Determinants of Health on COVID-related Mental Health Outcomes” has been approved for funding from the National Institute of Mental Health (Mental Health Research Grant, award number 1RF1MH134638-01). Led by Dr. Jordan Smoller (Harvard University, Massachusetts General Hospital), Dr. Sarah Bauermeister (University of Oxford), and Read more about COVID Global Mental Health Consortium Funded – 23 cohorts with 2.8 million participants[…]

Pan-Canadian Cancer Data Strategy

Posted on by pathwp

The Canadian Cancer Society (CCS) and Canadian Partnership Against Cancer (CPAC) have launched the Pan-Canadian Cancer Data Strategy that will guide efforts to enhance the collection, integration and use of cancer data. “CPAC and CCS have worked with various partners, including provincial and territorial cancer agencies and programs, healthcare organizations, First Nations, Inuit and Métis partners, Read more about Pan-Canadian Cancer Data Strategy[…]

CSEB Conference Update

Posted on by pathwp

The CanPath team was well represented at the Canadian Society for Epidemiology & Biostatistics (CSEB) Conference in Halifax on June 26-28, 2023. We had representatives from the CanPath National Coordinating Centre, Atlantic PATH, CARTaGENE, the Manitoba Tomorrow Project, and the Ontario Health Study that showcased the groundbreaking research and resources available related to epidemiology and biostatistics within CanPath and the regional cohorts. Read more about CSEB Conference Update[…]

CanPath Representation at the Canadian Society for Epidemiology and Biostatistics Conference

Posted on by pathwp

We’re so glad to have representation from Atlantic PATH, CARTaGENE, Manitoba Tomorrow Project, Ontario Health Study, and CanPath at the Canadian Society for Epidemiology and Biostatistics Conference in Halifax this week! CanPath and the regional cohorts are well represented in the following sessions: Monday, June 26, 2023 Workshop 1 – Mentorship for Junior Faculty and Funding Read more about CanPath Representation at the Canadian Society for Epidemiology and Biostatistics Conference[…]

CanPath Access Office Hours

Posted on by pathwp

The CanPath Access Office invites researchers to an Office Hours session. This virtual series provides researchers with an opportunity to ask questions about CanPath data and biosamples and the access process. Members of the Access Office will be available to answer questions and demonstrate how to navigate the CanPath Portal and online application. Registration: https://us02web.zoom.us/meeting/register/tZYsc-ugqD8sH9QfdxDq2NPHtBttkD17yCz1#/registration  

Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19

Posted on by pathwp

Dr. Victoria Kirsh presented at a CanPath webinar this week to present results from the SUPPORT-Canada study, funded by the federal COVID-19 Immunity Task Force (CITF). Data and blood spot samples were used from 22,300 participants from Atlantic PATH, CARTaGENE, the Ontario Health Study, Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and BC Generations. Key findings include: Read more about Most CanPath study participants had infection-acquired antibodies but few suspected COVID-19[…]

CanPath transforming data access to unlock its full potential to improve health

Posted on by pathwp

“New funding from Genome Canada will help CanPath build a cloud-based platform to equip researchers to understand the drivers of health and disease in Canada. Inside an unprecedented collection of health data from more than 330,000 Canadians are clues to understanding why people develop disease and how to prevent it. And a new project to improve Read more about CanPath transforming data access to unlock its full potential to improve health[…]

ISBER Awards

Posted on by pathwp

Congratulations to our colleague, Dr. Peter Watson on the Award for Outstanding Achievement in Biobanking from the International Society for Biological and Environmental Repositories!! We’re fortunate to work with Dr. Watson in his role with CanPath. Dr. Watson is the Director of Biobanking and Biospecimen Research Services, staff pathologist and senior scientist with BC Cancer. He Read more about ISBER Awards[…]